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Perfusion cardiovascular magnetic
resonance and fractional flow reserve in
patients with angiographic multi-vessel
coronary artery disease
Shazia T. Hussain1,9*, Amedeo Chiribiri2, Geraint Morton3, Nuno Bettencourt4, Andreas Schuster5, Matthias Paul6,
Divaka Perera7 and Eike Nagel8
Abstract
Background: Perfusion cardiovascular magnetic resonance (CMR) and fractional flow reserve (FFR) are emerging as
the most accurate tools for the assessment of myocardial ischemia noninvasively or in the catheter laboratory.
However, there is limited data comparing CMR and FFR in patients with multi-vessel disease. This study aims to
evaluate the correlation between myocardial ischemia detected by CMR with FFR in patients with multivessel
coronary disease at angiography.
Methods and results: Forty-one patients (123 vascular territories) with angiographic 2- or 3-vessel coronary artery
disease (visual stenosis >50 %) underwent high-resolution adenosine stress perfusion CMR at 1.5 T and FFR
measurement. An FFR value of <0.75 was considered significant.
On a per patient basis, CMR and FFR detected identical ischemic territories in 19 patients (46 %) (mean number of
territories 0.7+/−0.7 in both (p = 1.0)). On a per vessel basis, 89 out of 123 territories demonstrated concordance
between the CMR and FFR results (72 %). In 34 % of the study population, CMR resulted in fewer ischemic
territories than FFR; in 12 % CMR resulted in more ischemic territories than FFR. There was good concordance
between the two methods to detect myocardial ischemia on a per-patient (k =0.658 95 % CI 0.383-0.933) level and
moderate concordance on a per-vessel (k = 0.453 95 % CI 0.294–0.612) basis.
Conclusions: There is good concordance between perfusion CMR and FFR for the identification of myocardial
ischemia in patients with multi-vessel disease. However, some discrepancy remains and at this stage it is unclear
whether CMR underestimates or FFR overestimates the number of ischemic segments in multi-vessel disease.
Keywords: Ischemia, Fractional flow reserve, Coronary artery disease, Perfusion CMR
Background
Revascularization of patients with stable coronary artery
disease (CAD) should be guided by functional informa-
tion rather than anatomy [1, 2]. A large body of evidence
for the non-invasive assessment of ischemia is based on
single photon emission computed tomography (SPECT),
however, especially in the last decade, cardiovascular
magnetic resonance (CMR) has shown advantages such
as higher spatial resolution [3, 4] and potentially better
diagnostic accuracy [5].
Guiding revascularization by fractional flow reserve
(FFR) has demonstrated improved outcome in compari-
son to anatomy-guided strategies [6]. The accuracy of
CMR and FFR for the detection of CAD has been well
demonstrated and comparative studies have shown ex-
cellent diagnostic accuracy of perfusion CMR to detect
functionally significant CAD identified by FFR [3, 7].
However, there are limited data on their comparability
in defining ischemic segments in patients with multi-
vessel disease. Detection of 3VD with non-invasive
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imaging can be challenging due to the effects of bal-
anced ischemia leading to false-negative results in up to
20 % of cases [8]. A comparative accuracy study done by
Chung et al. [9] compared SPECT and perfusion CMR
in patients with angiographically proven three vessel dis-
ease and showed that CMR detected perfusion defects in
all three vascular territories in 57 % of patients vs only
11 % with SPECT. Data comparing SPECT and FFR have
also shown fewer ischemic territories with SPECT than
FFR in this group [10]. The low spatial resolution of
SPECT may also lead to underestimation of perfusion
defects [11].
It is unknown, whether the use of a high-resolution
perfusion technique such as CMR leads to improved
concordance for the identification of ischemic segments
in multi-vessel disease in comparison with FFR. The aim
of this study was to compare the extent of myocardial is-
chemia based on CMR and FFR in patients with angio-
graphically defined multi-vessel disease.
Methods
The study was approved by the Kings College London
(KCL) research ethics committee and all patients gave
written informed consent to participate. Potential partic-
ipants were identified after elective diagnostic coronary
angiography and informed consent was obtained. A total
of 41 patients with inclusion criteria of angina and stable
2- or 3-vessel disease designated on a visual basis by
angiography (diameter stenosis >50 %) were recruited.
All patients underwent FFR assessment during the sub-
sequent PCI procedure and CMR (performed as part of
the research protocol) which occurred prior (within
4 weeks) to the PCI procedure.
Exclusion criteria were contra-indications to CMR
(i.e., claustrophobia, metallic implant, pacemaker),
contra-indications to adenosine therapy, previous coron-
ary artery bypass graft (CABG), left main stem disease,
recent myocardial infarction (MI) within 6 months, un-
stable angina and left ventricular (LV) ejection fraction
<30 %.
CMR image acquisition
Data were acquired with a 1.5 T scanner (Achieva, Phi-
lips, Best, The Netherlands) using 32-channel coils. Ex-
aminations included high-resolution perfusion, cine and
scar imaging. Perfusion imaging consisted of 3 short axis
slices acquired every heartbeat covering 16 of the stand-
ard myocardial segments (apex excluded) [12] first dur-
ing adenosine stress followed by a short axis cine
imaging stack and then rest perfusion imaging. Imaging
parameters for perfusion imaging: kt BLAST acceleration
factor 5 SSFP sequence, shortest TE (range 1.35–
1.54 ms), shortest TR (range 2.64–3.12 ms), 50° flip
angle; 90° prepulse, 100 ms prepulse delay and typical
acquired resolution 1.7 × 1.9 × 10 mm. 0.075 mmol of
weight adjusted contrast agent (Gadobutrol/Gadovist,
Bayer Healthcare, Germany) was injected at 4 ml/s by a
power injector, followed by a 20 ml flush for stress im-
aging with adenosine infused according to a standard ad-
enosine protocol (140 μg/kg/min for 3 min, if no
response after 2 min increase to 170 μg/kg/min). There
was a 10 min delay between stress and rest imaging. The
cine images were completed with a set of long axis
views. Late Gadolinium enhancement (LGE) images
were acquired after 10 min (Gadovist 0.2 mmol/kg cu-
mulative dose) using an inversion recovery sequence.
CMR image analysis
Perfusion CMR images were analyzed by two experi-
enced observers blinded to the angiographic data and
clinical history (AC and SH). They reported all scans
with consensus; any disagreement was arbitrated by a
third reader (EN). The CMR images were also graded
for quality on a grading system of 1 (poor), 2(moderate)
and 3 (good).
A perfusion defect was defined as reduced contrast
uptake at peak stress persisting for 5 consecutive heart
beats but not present at rest. Corresponding late gado-
linium enhanced images were reviewed side by side with
the perfusion data and enhanced myocardium was disre-
garded for ischemia.
Designation of vascular territories was done according
to AHA 16 segment classification [13] Segments 1, 2, 7,
8, 13, and 14, were assigned to the left anterior descend-
ing coronary artery (LAD). Segments 3, 4, 9, 10, and 15
were assigned to the right coronary artery (RCA). Seg-
ments 5, 6, 11, 12, and 16 were assigned to the left cir-
cumflex artery (CX). This analysis was performed
without knowledge of angiographic variation as per clin-
ical practice.
Coronary angiography and FFR measurement
After obtaining arterial access, a standard Judkin’s tech-
nique was used to obtain angiographic views. Intracor-
onary pressure measurements were obtained in all
vessels that showed a ≥50 % diameter stenosis, assessed
angiographically, using a 0.014-inch intracoronary pres-
sure wire (Volcano Therapeutics, San Diego, CA, USA,
or Pressure-Wire Certus, St Jude Medical Systems AB,
Uppsala, Sweden). FFR was calculated during hyperemia
(intravenous adenosine infused at 140 micrograms kg/
min for at least 90 s) as Pd/Pa, where Pd and Pa are distal
coronary and aortic pressure respectively. In cases of serial
stenoses or when there was diffuse disease, the pressure
sensor was positioned beyond the most distal diseased
segment and if the FFR indicated hemodynamically signifi-
cant disease, this was ascribed to the most proximal lesion
for the purpose of this analysis. A FFR of <0.75 was
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considered significant. Coronary occlusions or lesions of
≥99 % were defined as FFR positive. Arteries with angio-
graphic plaque < 50 % diameter stenosis were defined as
FFR negative.
Statistical analysis
Data analysis was performed with SPSS version 20 (SPSS
Inc., Chicago Illinois). Continuous variables were pre-
sented as mean ± standard deviation (SD). The k statistic
values were derived to investigate per-patient and per-
vessel concordance between FFR and CMR derived evi-
dence for ischemia (a k statistic of +1 indicating perfect
agreement, 0 indicating agreement as expected by
chance, and −1 indicating complete disagreement). In
groups where kappa statistics could not be performed
(i.e., where the value in one group was constant) con-
cordance was assessed by percentage agreement.
A subgroup analysis according to different FFR
thresholds was also performed. Where possible the
kappa statistic was used, otherwise percentage agree-
ment was used.
Results
All 41 patients (29 males, average age 62 ± 9 years) and
123 territories were included in the analysis Table 1
summarizes the clinical characteristics of the patients
and the angiographic features. There was an adequate
stress response during the CMR scan with a mean heart
rate increase from 63 to 80 and an increase in rate pres-
sure product from 8243 to 9889. 27 were good quality
scans, 12 were moderate and 2 scans were of poor diag-
nostic quality Two patients had subendocardial scar,
none had transmural scarring. Within the 123 arteries,
there were 10 occluded vessels.
Comparison of CMR and FFR
If an angiographic cut-off of 50 % stenosis was used to
define patients with multivessel disease, 34 patients had
2VD and 7 pts had 3VD (See Fig. 1).
If an angiographic cut-off of 70 % stenosis was used 7
patients had 0 vessel disease (17 %), 9 patients 1- vessel
disease (22 %), 23 patients 2- vessel disease (56 %) and 2
patient 3- vessel disease (4 %).
Table 1 Pt clinical characteristics and angiographic details
Parameter Number or mean (+/− SD)
Age (years) 62 (9)
Sex (male) 30
Body Mass Index 27.8 (4.1)
CAD risk factors (%)
Diabetes 20.6
Hypertension 60.0
Smoking 14.3
Hypercholesterolaemia 93.3
Previous PCI 18.5
Previous myocardial infarction 4.0
Drug therapy (%)
Aspirin 81.5
Statin 80.0
B blocker 61.3
ACE I 29.6
Angiographic details
Vessels with FFR >0.75 72
Vessels with FFR ≤0.75 51
Abbreviations: ACEI angiotensin converting enzyme, FFR fractional flow
reserve, PCI percutaneous intervention
0%
25%
50%
75%
100%
CXA (50%) CXA (70%) FFR CMR
3VD
2VD
1VD
0VD
Fig. 1 Respective proportion of number of vascular abnormalities as described by Coronary angiography (based on a angiographic cut off of
50 % and 70 % stenosis), CMR and FFR (CXA = coronary x-ray angiography, CMR = cardiovascular magnetic resonance, FFR = fractional
flow reserve)
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CMR demonstrated no perfusion defect in 10 patients
(24 %), ischemia in one territory in 20 (49 %) patients,
two territories in 11 patients (27 %) and 3 territories in
one patient (2 %). All cases were read with consensus
between two readers with only two cases requiring a
third observer.
FFR results were negative in all vessels in 9 patients
(22 %), positive in 1 vessel in 16 patients (39 %), in 2
vessels in 13 patients (32 %) and 3 vessels in 3 patients
(7 %).
The mean number of territories identified per patient
was 1.0 ± 0.8 by CMR and 1.2 ± 0.9 by FFR.
Concordance between FFR and CMR
In 22 patients (54 %), there was complete agreement as
to the number of territories of ischemia: mean number
of territories 0.7 ± 0.7 for both (p = 1.0). Of these there
was concordance in territories identified in 93 % of
patients.
In 6 patients (15 %), CMR showed more ischemic ter-
ritories than FFR, in 13 patients (32 %), CMR showed
fewer ischemic territories than FFR (See Table 2).
The classification of 91 out of 123 territories (74 %)
was identical with CMR and FFR; of the discordant
territories, 21 (17 %) were CMR negative and FFR
positive and 11 (9 %) CMR positive and FFR negative
(See Figs. 2 and 3).
Overall, there was good concordance between the two
methods on a per patient basis (k =0.658) and a fair con-
cordance on a per vessel basis (k = 0.433) (See Table 3).
Concordance between CMR and FFR for various FFR
thresholds
Lowering the FFR threshold for FFR improves the per-
centage agreement for a positive FFR from 56 to 64 %
(See Table 4) for result.
Discussion
Our data shows good concordance between CMR and
FFR for the identification of myocardial ischemia in pa-
tients with angiographic multi-vessel disease. On a per
vessel basis, 91 out of 123 territories demonstrated
concordance between the CMR and FFR results (74 %).
On a per patient basis there was complete concordance
of number and localization of territories in 46 % of pa-
tients. However, for the presence of ischemia alone,
there is 88 % concordance on a per patient basis.
Despite the high resolution of perfusion CMR, in one
third of patients, CMR demonstrated a lower number of
ischemic territories than FFR. Agreement was best at the
extremes of FFR but less strong for intermediate values.
The “true” gold standard functional test
Whilst trying to understand the causes of discrepancy
between the two tests, it is important to understand
that neither of the tests is a true gold standard for is-
chemia assessment. FFR is recognized to be highly re-
producible measure of ischemia [14] but also has a
number of limitations. Originally, FFR was validated
against a number of non-invasive imaging modalities,
with a Bayesian statistical analysis. This involved a
combination of all tests as the reference standard and
demonstrated a sensitivity of FFR in the identification
of reversible ischemia of 88 % with a specificity of
100 % in patients with single-vessel disease [15]. A
meta- analysis of FFR vs QCA and non-invasive im-
aging by Christou et al. demonstrated less favorable
results with a sensitivity and specificity of 76 % and
76 % of FFR compared with non-invasive imaging
[16]. As such, discrepant results cannot be assigned
to one technique or the other, but should be consid-
ered as differences.
Discrepancy between CMR and FFR results
In our study, we demonstrate underestimation by CMR
or overestimation by FFR in 33 % of cases. There are
four main reasons why two methods measuring the sig-
nificance of a coronary stenosis may differ:
1.) They measure a different pathophysiology and as
such have different definitions of a significant
coronary stenosis.
2.) They use different cut-off values to determine
“significance”.
3.) A significant stenosis is assigned to a different
coronary artery/segment.
4.)One of the two tests or both do not measure what
they claim to measure.
In the current study each of the four elements contrib-
utes to the observed differences.
Pathophysiology
There are physiological differences in the measures of is-
chemia by the two tests that may contribute to discrep-
ancies. Stress perfusion CMR indicates altered coronary
Table 2 Concordance between CMR and FFR on a per patient
basis according to number of significant FFR values and CMR
perfusion defects
FFR result
0 1 2 3
CMR result 0 7 2 0 1
1 1 11 8 0
2 1 3 4 2
3 0 0 1 0
Abbreviations: CMR cardiovascular magnetic resonance, FFR fractional
flow reserve
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flow reserve (CFR) assessed by contrast delivery through
the entire vasculature of the heart and FFR measures the
impact of a coronary stenosis on myocardial perfusion in
the territory subtended by that vessel and relies on sev-
eral assumptions regarding minimal microvascular re-
sistance, which may not be true in all cases.
The influence of the microvasculature is important
both as a cause of discrepancy, and also in terms of
prognosis. An assessment of this is neglected by FFR,
which assumes minimal microvascular resistance, but is
incorporated within stress perfusion which assesses the
whole vascular compartment. In a recent study [17], pa-
tients with intermediate stenoses were assessed by both
coronary flow velocity reserve and FFR and patients with
a normal FFR but an abnormal coronary flow velocity
reserve had a significantly higher major adverse cardiac
event rate throughout 10 years of follow-up, regardless
of the FFR cut-off applied. Since CMR measures perfu-
sion on a myocardial level, it is plausible that such a dis-
crepancy manifests as a CMR perfusion defect in the
presence of a negative FFR.
Cut-off values
The sensitivity and specificity of a test can be altered by
changing the cut-off value used. In the original valid-
ation studies the cut-off value for FFR was set at 0.75
[15], although subsequent studies have used a cut-off of
0.80 [18]. The different cut-off values may explain some
of the variation of concordance between FFR and nonin-
vasive imaging in the literature. A study by Melikian et
al.[10] used 0.8 as the cut-off value and found poor con-
cordance between SPECT and FFR in patients with
multi-vessel disease (k = 0.14 on a per patient and k =
0.28 on a per vessel basis). A study by Ragosta et al. [19]
Fig. 2 Case example of concordance between FFR value and CMR. Angiographic images and corresponding perfusion images of a patient with 2-
vessel disease. The LAD has a proximal stenosis (FFR value 0.63) (see arrow) resulting in a perfusion defect in the anterior wall visible in the apical, mid
and basal ventricular slice. The RCA has a distal stenosis (FFR value 0.62) (see arrow) resulting in a perfusion defect in the inferior wall visible in the basal
and mid slice. (Abbreviations: CMR = cardiovascular magnetic resonance, FFR = fractional flow reserve, LAD = left anterior descending artery, RCA = right
coronary artery)
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used <0.75 as the cut-off value and found better con-
cordance (69 %). In the current study, we demonstrate
that reducing the FFR cut-off value results in improved
agreement for positive results, while increasing the cut-
off value results in improved agreement for negative re-
sults. The resulting accuracy is highly dependent on
prevalence but the greatest disparity between FFR and
CMR occurred between values of 0.7–0.8. A recent
meta-analysis by Johnson et al.[20] assessing outcomes
in over 9000 lesions evaluated by FFR found the optimal
FFR threshold for a composite endpoint of death, MI,
and revascularization at 0.67. Interestingly, the FAME 2
data [21] also showed larger benefit for PCI when FFR
was <0.65 with a smaller benefit when FFR was >0.65.
Whether a lower or higher threshold value is more im-
portant for clinical guidance remains unknown for the
time being. There is, however, a general tendency to-
wards less revascularization in mild ischemia making a
trend towards stricter cut-off values likely.
Similarly, varying the CMR thresholds will result in a
variation of concordance with FFR. Our hypothesis was
that the higher spatial resolution of perfusion CMR com-
pared to SPECT would result in a higher concordance
with FFR due to a better visualization of small perfusion
defects. Interestingly, in the majority of discrepant cases
in our study, the stenosis with the lowest FFR was
Fig. 3 Case Example of discordance between the FFR value and CMR. Angiographic images and corresponding perfusion images of a patient
with 2-vessel disease. The LAD has a distal stenosis (FFR value 0.7) (arrow) with no associated perfusion defect. The RCA has a proximally occluded
artery (arrow) resulting in a perfusion defect in the inferior wall visible in all three slices. The combination of a distal lesion and a mildly positive
FFR value in the LAD results in no demonstrable ischemia in the anterior wall. (Abbreviations: CMR = cardiovascular magnetic resonance, FFR =
fractional flow reserve, LAD = left anterior descending artery, RCA = right coronary artery)
Table 3 Per vessel and per patient concordance between CMR
and FFR
CMR FFR result
Per vessel Per patient
>0.75 ≤0.75 >0.75 ≤0.75
Negative 60 21 7 3
Positive 11 31 2 29
Concordance for the detection of ischemia between CMR perfusion imaging
and fractional flow reserve on a per vessel and a per patient basis
Abbreviations: CMR cardiovascular magnetic resonance, FFR fractional
flow reserve
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identified with both techniques, while less severe FFR re-
sults were not seen with perfusion CMR. With SPECT it
was suggested [19], that the stenosis with the greatest is-
chemia is the most evident, leading to visual neglect of
subtler perfusion abnormalities. With CMR this is less
likely, since perfusion defects usually show as subendocar-
dial defects with normal epicardial perfusion. This allows
assessing each coronary artery territory independent of
other territories. A recent study by Motwani et al. [22]
demonstrated an increase in abnormal territories identi-
fied with higher spatial resolution (29 % by standard reso-
lution and 57 % by high resolution imaging (p = 0.04)) due
to a better visualization of subendocardial defects. How-
ever, this may also have been influenced by a higher con-
trast agent dose used in the high resolution scan. Our
study demonstrated concordance on a per vessel level of
74 % which is an improvement on previous studies and
may reflect the advantages of higher resolution scanning.
Variable assignment of perfusion territories
Any study that compares a non-invasive with an invasive
technique will be limited by the inability to define exact
coronary territories by the 17 segment AHA model.
Overlap of segments between the coronary arteries may
lead to mis-assignment thus affecting concordance. Add-
itionally, in 2- vessel disease, depending on the func-
tional severity of one stenosis compared with the other,
it may be difficult to separate out two small areas of is-
chemia from one larger more confluent area, again af-
fecting concordance.
The majority of validation studies for both CMR and
FFR have been done in a single vessel population, and
our data suggests that it is difficult to extrapolate those
results to apply to a more complex multivessel popula-
tion. There are many physiological variables that can
affect FFR measurement i.e., presence of scar, collaterals,
FFR in small diameter vessels, microvascular dysfunction
etc. and these are more likely to be present in patients
that have extensive CAD such as our patient population.
While in general FFR is normalized for the perfusion
area subtended by the interrogated vessel, even a highly
positive FFR in a small vessel may only lead to a small
amount of myocardial ischemia not detectable by CMR.
Study limitations
The main limitation of this study is the use of qualitative
visual analysis. Quantitative or semi-quantitative perfu-
sion analyses may further improve concordance and ac-
curacy as recently shown in a study comparing visual
and semi-quantitative perfusion CMR versus invasive
angiography in patients with known or suspected CAD
[23]. We have used visual analysis for the identification
of perfusion defects as this is more applicable to clinical
practice and our goal was the determination of similar-
ities and differences between two clinically used tests.
Conclusion
This study shows that CMR has good concordance with
FFR on a per patient level for the demonstration of is-
chemia, making it an excellent non-invasive alternative
to identify patients suitable for invasive angiography
However, some discrepancies remain in the identifica-
tion of multiple perfusion defects in patients with multi-
vessel disease. There is a general tendency for CMR to
shows fewer diseased vessels than FFR. At this stage it is
unclear whether CMR underestimates or FFR overesti-
mates the number of ischemic segments in multi-vessel
disease, and thus the utility in using CMR to guide re-
vascularization in these patients remains unresolved.
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